Target intelligence / Profile preview

Innate immune cells and membranes

Molecular classification
Other
01

Overview

Innate immune cells and membranes refer to the collective group of cells—such as macrophages, neutrophils, dendritic cells, and natural killer cells—and their associated lipid bilayers that initiate the body's primary, non-specific defense. These cells utilize a vast array of membrane-bound and cytoplasmic pattern recognition receptors (PRRs) to detect pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) (NIH, 2023). The membranes are not merely structural barriers but serve as dynamic platforms for signaling complexes and phagocytic machinery essential for host defense and homeostasis. Dysregulation of innate immune cell activity is a hallmark of various pathologies, including sepsis, rheumatoid arthritis, and the tumor microenvironment (Nature Reviews Immunology, 2021). Although this term describes a broad biological system or compartment rather than a single molecular entity, it is a focal point for drug development aimed at modulating immune activity through specific receptors like Toll-like receptors (TLRs) or the NLRP3 inflammasome (PubMed, 2022). Consequently, understanding the composition and function of these cells and their membranes is vital for the development of immunomodulatory therapies and targeted drug delivery systems.

Other names
Innate immune systemMyeloid cell membranesNon-specific immune cellsInnate immunity components
02

Mechanism of action

Modulation of innate immune signaling pathways and membrane-bound receptor activity to either stimulate or suppress immune responses.

03

Biological functions

Immune responseInflammationPathogen recognitionPhagocytosisSignal transductionAntigen presentation
04

Disease associations

InflammationInfectionCancerAutoimmune diseaseSepsisMetabolic disorders
05

Safety considerations

Cytokine release syndromeSystemic inflammatory response syndromeIncreased susceptibility to opportunistic infectionsAutoimmune reactionsTissue damage from chronic activation
06

Interacting drugs

Imiquimod

5 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)CD14CD11bProcalcitonin

Beyond the preview

Go deeper on Innate immune cells and membranes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innate immune cells and membranes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call